Healthcare -
Biotechnology - NASDAQ - US
$ 0.356
-49.1 %
$ 129 M
Market Cap
-0.48
P/E
LXRX - TOTAL CURRENT ASSETS
Total Current Assets LXRX - Lexicon Pharmaceuticals, Inc.
177 M
LAST VALUE
40.91%
2 YEAR CAGR
0.37%
5 YEAR CAGR
2.75%
10 YEAR CAGR